New Delhi, March 21 (IANS) Three Indian pharmaceutical companies have launched generic versions of semaglutide injections, after the drug’s patent expired, offering lower‑cost options for patients managing Type 2 diabetes and obesity.The companies, namely Sun Pharma, Zydus Lifesciences, and Dr. Reddy’s Laboratories, launched their variants a day after Hyderabad-based Natco Pharma launched its generic semaglutide injection in India, priced at Rs 1,290 per month.Sun Pharma launched semaglutide…
Trending
- Mathe Male Hoyyuthide Review: A Heartfelt Generational Love Story Set in the Rains of Malenadu
- M4M – Motive for Murder Review: A Gripping Telugu Crime Thriller That Turns Murders into Masterpieces
- Ankam Attahasam Movie Review (2026): Madhav Suresh’s Gritty Trivandrum Gangster Drama Is a Raw, Riveting Ride
- Citadel Season 2 Review (2026): Priyanka Chopra, Richard Madden & Stanley Tucci Make This Prime Video Thriller Unmissable
- Dridam Movie Review: Shane Nigam’s Slow-Burn Cop Drama Is Gripping — Until It Isn’t
- 29 Movie Review: A Heartfelt Romantic Drama That Blooms in Its Own Time
- Razor Movie Review (2026): Ravi Babu Delivers a Gripping Survival Thriller
- Sathi Leelavathi Review (2026): Lavanya Tripathi Shines in This Heartfelt Family Entertainer